AbbVie · 1 day ago
2026 Clinical Supply Project Management Intern
AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The Clinical Supply Project Management intern will work with the Clinical Drug Supply Management department to understand clinical development plans and ensure the effective planning and distribution of clinical supplies for trials.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Understanding the major factors that influence demand for clinical supplies and the different strategies utilized to ensure uninterrupted supply
Using available data to look for trends and opportunities to improve processes and decision making
Analyzing business processes to understand current requirements and workflows with the aim of helping colleagues identify opportunities for efficiency
Qualification
Required
Currently enrolled in university, pursuing a Bachelor's in Supply Chain, Project Management, Engineering or other related field
Must be enrolled in university for at least one semester following the internship
Expected graduation date between December 2026 – June 2027
Preferred
Exposure to data analytics, design of experiments, supply chain, manufacturing, planning, scheduling, forecasting, Lean Six-Sigma concepts
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-06
BioWorld Financial Watch
2026-01-04
Company data provided by crunchbase